-
Medicare is experimenting with how it pays for kidney transplants
The troubled U.S. kidney transplant system is about to get an overhaul. Or at least, half of it is. On July 1, 2025, a mandatory new payment structure for kidney transplants kicks in. The idea behind the Increasing Organ Transplant Access (IOTA) Model is to determine whether financial incentives for hospitals lead to more transplants,…
-
Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures
Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures While Talaris Therapeutics is ending two clinical tests of its cell therapy in kidney transplant patients, a third study in the autoimmune condition scleroderma is continuing. Meanwhile, the biotech’s restructuring plan is pursuing “strategic alternatives” that could include a merger or sale. Information Courtesy By:…
Got any book recommendations?